- Decision: Reject
- Avg Score: 4.50
- Scores: 3, 5, 5, 5
Now I have all the information I need. Let me construct the final consolidated review.

## Summary
This paper presents PODGenGraph, a benchmark evaluating graph pre-trained models (ContextPred, AttrMask, Mole-BERT, InfoGraph, etc.) against specialized OOD methods (CIGA, MoleOOD, LiSA) across 19+ datasets spanning molecular graphs and general graphs, under both covariate and concept shifts. The central finding is that pre-trained models achieve highest or second-highest performance on all 19 molecular OOD test sets, often surpassing methods explicitly designed for OOD. The paper also studies sample efficiency, learning rate effects, and the correlation between ID and OOD performance.

## Strengths
- **Strong molecular-domain evidence**: Table 2 shows that across all 19 molecular OOD test sets (DrugOOD, MoleculeNet, OGBG, TU), pre-trained models achieve the highest or second-highest performance among all methods (including invariant/causal methods CIGA, MoleOOD and augmentation method LiSA). This is a concrete, well-supported finding.
- **Novel empirical findings for graph OOD**: Figure 2(d) shows no clear correlation between ID and OOD performance for graph pre-trained models, directly contradicting the "accuracy on the line" phenomenon (Miller et al., 2021) observed in other domains. Similarly, Figure 2(c) shows that only Mole-BERT benefits from smaller fine-tuning learning rates, unlike image-domain findings.
- **Sample efficiency demonstration**: Figure 2(b) shows that pre-trained models retain competitive OOD performance with as little as 20% of the original fine-tuning data, a practically useful property that the paper documents across multiple data fractions.
- **Broad and systematic evaluation framework**: The benchmark covers 19 datasets from DrugOOD, MoleculeNet, OGBG, TU collection, and general graphs, spans both covariate and concept shifts, and varies shift degrees (Figure 2(a)). This breadth lends weight to the findings.
- **Robust statistical reporting**: Results are averaged over 10 random seeds, and the paper additionally reports median, interquartile mean (IQM), and optimality gap (Appendix Figs. A2-A3), going beyond simple mean/std tables.

## Weaknesses

### Fatal
None.

### Major
- **Missing backbone architecture for OOD baselines**: The paper specifies "5-layer GINs with 300 hidden units as the backbone model for all pre-training methods" (Section 4.2) but does **not** state what backbone architecture CIGA, MoleOOD, and LiSA use. Without this information, it is impossible to determine whether observed performance gaps arise from the method itself or from architectural differences. This is a basic reproducibility gap.
- **External data confound not acknowledged or controlled**: Pre-trained models (ContextPred, AttrMask, Mole-BERT) are initialized from weights learned on 2 million molecules from ZINC-15, while the OOD-specific methods (CIGA, MoleOOD, LiSA) are trained from scratch on the downstream datasets. The paper presents this as "pre-training surpasses specialized OOD methods" without explicitly discussing or controlling for the fact that the pre-trained models have seen orders of magnitude more training data. The central claim conflates the benefit of pre-training with the benefit of additional data. The paper should at minimum acknowledge this asymmetry as a limitation and discuss whether it affects the interpretation.

### Minor
- **Sample efficiency claim uses an asymmetric comparison**: The paper states that with only 20% of the fine-tuning sample size, pre-trained models "achieve comparable performances compared with baselines (baseline results are in Table 2)" — but Table 2 shows baselines trained on 100% of the data. Comparing pre-trained models at 20% data against baselines at 100% data inflates the apparent sample efficiency. A symmetric comparison (pre-trained vs. baselines at the same data fraction) would better support the claim. The finding itself remains interesting but the framing is misleading.
- **Inconsistency in learning rate claim**: The body text (Section 4.3, "Effect of the Fine-tuning Learning Rates") opens with "models fine-tuned with smaller learning rates achieve better generalization capabilities," but the subsequent results show this only holds for Mole-BERT and not for ContextPred or AttrMask. The abstract correctly states the nuanced finding. The body text needs correction to match its own evidence.
- **Title and framing overemphasize universality**: The title "The Unreasonable Effectiveness of Pretraining in Graph OOD" and the abstract's broad language imply a general phenomenon, but the evidence is overwhelmingly molecular-domain-driven (pre-training wins on all 19 molecular test sets but underperforms GIN-OOD on CMNIST). The paper does acknowledge general-graph limitations (third bullet in Introduction), but the overall framing does not reflect this domain specificity proportionally.

### Trivial
None.

## Nice-to-Haves
- The shift degree measure (ΔS) is computed using a single vanilla GNN's performance drop. Using multiple GNN architectures to assess stability would strengthen the measure. This is not a flaw but a refinement.
- The ID-vs-OOD correlation analysis (Figure 2(d)) covers only three pre-trained models on two dataset families. Expanding this to more methods and datasets would strengthen what is currently a preliminary observation.
- Pre-training dataset (ZINC-15) overlap with downstream molecular datasets is not discussed. A brief discussion of potential overlap and its implications would be valuable.

## Removed Points
- **GraphCL not appearing in results**: The paper describes GraphCL in Section 3.2, but Table 2 is an image and cannot be definitively checked from the text. This point is potentially correct but unverifiable from the text alone. Removed for lack of evidence.
- **Criticisms about the comparison being "structurally unsupported" / requiring a redesign**: The core question of the benchmark — "should practitioners use a pre-trained model or train an OOD method from scratch?" — is legitimate and well-motivated. The external data advantage is inherent to the concept of pre-training. While the confound should be discussed, it does not invalidate the comparison framework. Removed as overstatement; downgraded to Major.
- **Speculative concerns about ZINC-15 overlap, appendix content, or missing supplementary materials**: These reflect reviewer assumptions about content not present in the submission, not verifiable from the paper. Removed per instructions.
- **Criticism that standard deviations make differences "within noise"**: With variances up to ±0.1 ROC-AUC on some DrugOOD tasks, the differences could be small relative to noise. However, the paper reports across 10 seeds and also shows median/IQM/optimality gap; this criticism is too vague without specific statistical testing. Kept as a minor concern but the harsh critic overstated it. Absorbed into the general statistical discussion.

## Novel Insights
The most striking insight from combining the two reviews is that the paper's evidence is far stronger than either reviewer individually accounts for when considered at the right granularity. The harsh critic focuses on the "unfair comparison" framing but does not grapple with the fact that the paper is benchmarking a practical question (pre-trained vs. from-scratch), not a controlled ablation. The strength finder correctly identifies the molecular-domain evidence as strong but does not fully weigh the severity of the missing backbone specification for baselines. The cross-cutting tension is that the paper's scope is simultaneously its greatest strength (19 datasets, multiple shifts, thorough statistics) and the source of its clearest weaknesses (comparison confounds acknowledged only partially, key implementation details omitted for baselines). An underexplored synthesis: the paper would be substantially more convincing if it ran one control experiment — pre-training CIGA/LiSA on ZINC-15 — which would cleanly separate the "pre-training procedure" effect from the "external data" effect and either validate or bound the central claim.

## Suggestions
1. **Specify backbone architectures for all baselines** (CIGA, MoleOOD, LiSA) explicitly in the paper, or cite the original implementations used.
2. **Add a brief discussion** of the external data advantage (2M ZINC-15 molecules vs. from-scratch training) as a recognized confound, and ideally run at least one control experiment (e.g., pre-training one OOD method on ZINC-15).
3. **Correct the learning rate statement** in the body text to match the actual finding: smaller learning rates only help Mole-BERT.
4. **Re-frame the sample efficiency claim** to compare pre-trained and non-pre-trained methods at the same data fraction, or clarify the asymmetric nature of the current comparison.
5. **Tone down the title/framing** to reflect the molecular-domain strength and general-graph limitations more proportionally (e.g., "The Unreasonable Effectiveness of Pretraining for Molecular Graph OOD").
